Relmada Therapeutics names Bipin Dalmia chief business officer

Reuters2026/07/28 12:30

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Relmada named Bipin Dalmia as chief business officer, leading corporate strategy, commercial planning, business development; reporting to CEO Sergio Traversa.
Dalmia brings nearly three decades in biopharma leadership, spanning NMIBC, corporate strategy, business development.
Appointment aligns with NDV-01 program as Relmada moves toward late-stage development for its sustained-release intravesical NMIBC therapy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607280830PRIMZONEFULLFEED9798974) on July 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Relmada Therapeutics names Bipin Dalmia chief business officer

You may also like

Crypto prices